Phase I trial of daily pomalidomide in patients with advanced solid tumors

被引:3
|
作者
Cooney, M. M.
Bokar, J. A.
Dreicer, R.
Krishnamurthi, S. S.
Savvides, P.
Nock, C. J.
Rodal, M. B.
Henderson, L.
Dowlati, A.
机构
[1] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[3] Univ Hosp Case Med Ctr, Cleveland, OH USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.e13077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13077
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors
    Stephen V. Liu
    Susan G. Groshen
    Karen Kelly
    Karen L. Reckamp
    Chandra Belani
    Timothy W. Synold
    Amir Goldkorn
    Barbara J. Gitlitz
    Mihaela C. Cristea
    I-Yeh Gong
    Thomas J. Semrad
    Yucheng Xu
    Tong Xu
    Marianna Koczywas
    David R. Gandara
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 723 - 732
  • [32] Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
    Nardo, Mirella
    Gouda, Mohamed A.
    Reilley, Matthew J.
    Biter, Amadeo B.
    Lim, Joann
    Bean, Stacie A.
    Nguyen, Ly M.
    Bhosale, Priya R.
    Ager, Casey R.
    Couillault, Coline A.
    Piha-Paul, Sarina A.
    Fu, Siqing
    Tsimberidou, Apostolia M.
    Yap, Timothy A.
    Naing, Aung
    Rodon, Jordi
    Subbiah, Vivek
    Karp, Daniel D.
    Curran, Michael A.
    Hong, David S.
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2025, 8 (02) : 89 - 98
  • [33] Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
    Camacho, Luis H.
    Olson, Jon
    Tong, William P.
    Young, Charles W.
    Spriggs, David R.
    Malkin, Mark G.
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (02) : 131 - 138
  • [34] Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors
    Luis H. Camacho
    Jon Olson
    William P. Tong
    Charles W. Young
    David R. Spriggs
    Mark G. Malkin
    Investigational New Drugs, 2007, 25 : 131 - 138
  • [35] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [36] Sunitinib and bevacizumab in advanced solid tumors: A phase I trial
    Cooney, M. M.
    Garcia, J. A.
    Elson, P.
    Mekhail, T.
    Dreicer, R.
    Nock, C. J.
    Bokar, J. A.
    Tyler, A.
    Beatty, K.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Phase I trial of gemcitabine and paclitaxel in advanced solid tumors
    Lim, N
    Lara, PN
    Lau, DHM
    Edelman, MJ
    Tanaka, M
    Al-Jazayrly, G
    Houston, J
    Lauder, I
    Gandara, DR
    CANCER INVESTIGATION, 2003, 21 (01) : 7 - 13
  • [38] Phase I clinical trial of daily imatinab mesylate (Gleevec) and weekly Paclitaxel in patients with advanced refractory solid tumors.
    Bahrani, A
    Hwang, J
    Egorm, MJ
    Barmen, P
    Ramzi, P
    Marshall, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6252S - 6252S
  • [39] A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma.
    Mehnert, Janice M.
    Semlani, Neha
    Wen, Yvonne
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Adams, Shari
    Stein, Mark N.
    Ross, Mikel
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    Chen, Suzie
    Goydos, James S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)